ML
CVS icon

McAdam LLC’s CVS Health CVS Stock Holding History

McAdam LLC’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$450K Buy
4,352
+555
+15% +$49.5K 0.02% 292
2026
Q1 		$273K Buy
3,797
+194
+5% +$14.9K 0.01% 361
2025
Q4 		$286K Buy
3,603
+771
+27% +$60.8K 0.01% 333
2025
Q3 		$214K Buy
+2,832
New +$194K 0.01% 374
2024
Q4 		– Sell
-4,354
Closed -$274K – 358
2024
Q3 		$274K Buy
+4,354
New +$254K 0.02% 274
2020
Q2 		– Sell
-3,885
Closed -$231K – 128
2020
Q1 		$231K Sell
3,885
-183
-4% -$12.2K 0.06% 90
2019
Q4 		$302K Buy
4,068
+699
+21% +$49.1K 0.07% 60
2019
Q3 		$213K Buy
+3,369
New +$200K 0.06% 74
2019
Q2 		– Sell
-5,342
Closed -$288K – 76
2019
Q1 		$288K Buy
+5,342
New +$330K 0.1% 53
2018
Q4 		– Sell
-2
Closed – – 167
2018
Q3 		$0 Hold
2
– – ﹤0.01% 672
2018
Q2 		$0 Sell
2
-53
-96% -$3.49K ﹤0.01% 669
2018
Q1 		$3K Buy
+55
New +$3.95K ﹤0.01% 462

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

McAdam LLC's CVS Position: Q2 2026 in Review

McAdam LLC increased its CVS Health (CVS) stake by 15% in Q2 2026, buying an estimated $49.5K and bringing the position to 4,352 shares worth $450K. The position accounts for 0.02% of the portfolio, ranked #292.

McAdam LLC first reported a position in CVS in Q1 2018 and has held it in 12 quarters since. 2,067 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • McAdam LLC held 4,352 shares of CVS Health worth $450K as of Q2 2026.
  • McAdam LLC bought 555 CVS Health shares in Q2 2026, an estimated $49.5K.
  • CVS Health made up 0.02% of McAdam LLC's portfolio in Q2 2026, its #292 holding.
  • McAdam LLC first reported a position in CVS Health in Q1 2018 and has held it in 12 quarters since.
  • 2,067 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on McAdam LLC's 13F filing for Q2 2026, filed 4 Aug 2026.